Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Transcode Therapeutics Inc (RNAZ)

Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
TransCode Therapeutics Open Letter to Shareholders GlobeNewswire - Tue Nov 12, 6:00AM CST

RNAZ : 0.3800 (+13.03%)
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance GlobeNewswire - Tue Nov 5, 6:00AM CST

RNAZ : 0.3800 (+13.03%)
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data GlobeNewswire - Wed Oct 23, 6:00AM CDT

RNAZ : 0.3800 (+13.03%)
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology GlobeNewswire - Thu Oct 10, 6:00AM CDT

RNAZ : 0.3800 (+13.03%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise FinancialNewsMedia - Tue Sep 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END

BMY : 58.23 (+0.60%)
ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.3800 (+13.03%)
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...

ONC.TO : 1.37 (-2.14%)
ONCY : 0.9800 (-1.85%)
VACC : 5.00 (+11.36%)
BPTS : 8.22 (-15.28%)
RNAZ : 0.3800 (+13.03%)
BMY : 58.23 (+0.60%)
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028 FinancialNewsMedia - Thu Dec 8, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NYSE:BMY),(NASDAQ:RXDS),(NASDAQ:RNAZ) EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
GILD : 89.76 (+1.27%)
RXDX : 199.92 (+0.09%)
RNAZ : 0.3800 (+13.03%)
BMY : 58.23 (+0.60%)
Biotechs Race for New Treatments as Breast Cancer Therapeutics Market Could Reach $15 Billion by 2028 PR Newswire - Thu Dec 8, 2022

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - According to a report from Global Market Insights the Breast Cancer Therapeutics Market size, which...

ONC.TO : 1.37 (-2.14%)
ONCY : 0.9800 (-1.85%)
GILD : 89.76 (+1.27%)
BMY : 58.23 (+0.60%)
RXDX : 199.92 (+0.09%)
RNAZ : 0.3800 (+13.03%)
Biotech Sees Massive Rally On Major Announcement Yolowire - Wed Dec 7, 2022

A Boston-based %Biotech company caught the attention of the trading community on Wednesday after it was announced that the company withdrew the Registration Statement on Form S-1 it filed with the U.S....

RNAZ : 0.3800 (+13.03%)
Biotechs with Evolving Therapies Have Potential to Revolutionize Treatments for Pancreatic Cancer FinancialNewsMedia - Thu Nov 10, 2022

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MACK),(NASDAQ:NRBO),(NYSE:MRK),(NASDAQ:RNAZ), EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
MACK : 15.13 (unch)
NRBO : 2.35 (-2.08%)
MRK : 99.86 (+2.48%)
RNAZ : 0.3800 (+13.03%)

Barchart Exclusives

S&P Futures Tick Lower Ahead of U.S. PMI Data Barchart - 16 minutes ago
December S&P 500 E-Mini futures (ESZ24) are trending down -0.25% this morning as investors geared up for U.S. business activity data. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot